MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/jamapediatrics.2017.5211

Медицинская библиотека · JAMA pediatrics · 2018

Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy.

Grinspan Zachary M, Shellhaas Renée A, Coryell Jason, Sullivan Joseph E, Wirrell Elaine C, Mytinger John R, Gaillard William D, Kossoff Eric H, Valencia Ignacio, Knupp Kelly G, Wusthoff Courtney, Keator Cynthia, Ryan Nicole, Loddenkemper Tobias, Chu Catherine J, Novotny Edward J, Millichap John, Berg Anne T

Сравнительное исследованиеСтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

IMPORTANCE

More than half of infants with new-onset epilepsy have electroencephalographic and clinical features that do not conform to known electroclinical syndromes (ie, nonsyndromic epilepsy). Levetiracetam and phenobarbital are the most commonly prescribed medications for epilepsy in infants, but their comparative effectiveness is unknown.

OBJECTIVE

To compare the effectiveness of levetiracetam vs phenobarbital for nonsyndromic infantile epilepsy.

DESIGN, SETTING, AND

PARTICIPANTS

The Early Life Epilepsy Study-a prospective, multicenter, observational cohort study conducted from March 1, 2012, to April 30, 2015, in 17 US medical centers-enrolled infants with nonsyndromic epilepsy and a first afebrile seizure between 1 month and 1 year of age.

EXPOSURES: Use of levetiracetam or phenobarbital as initial monotherapy within 1 year of the first seizure.

MAIN OUTCOMES AND MEASURES: The binary outcome was freedom from monotherapy failure at 6 months, defined as no second prescribed antiepileptic medication and freedom from seizures beginning within 3 months of initiation of treatment. Outcomes were adjusted for demographics, epilepsy characteristics, and neurologic history, as well as for observable selection bias using propensity score weighting and for within-center correlation using generalized estimating equations.

RESULTS

Of the 155 infants in the study (81 girls and 74 boys; median age, 4.7 months [interquartile range, 3.0-7.1 months]), those treated with levetiracetam (n = 117) were older at the time of the first seizure than those treated with phenobarbital (n = 38) (median age, 5.2 months [interquartile range, 3.5-8.2 months] vs 3.0 months [interquartile range, 2.0-4.4 months]; P < .001). There were no other significant bivariate differences. Infants treated with levetiracetam were free from monotherapy failure more often than those treated with phenobarbital (47 [40.2%] vs 6 [15.8%]; P = .01). The superiority of levetiracetam over phenobarbital persisted after adjusting for covariates, observable selection bias, and within-center correlation (odds ratio, 4.2; 95% CI, 1.1-16; number needed to treat, 3.5 [95% CI, 1.7-60]).

CONCLUSIONS AND RELEVANCE: Levetiracetam may have superior effectiveness compared with phenobarbital for initial monotherapy of nonsyndromic epilepsy in infants. If 100 infants who received phenobarbital were instead treated with levetiracetam, 44 would be free from monotherapy failure instead of 16 by the estimates in this study. Randomized clinical trials are necessary to confirm these findings.

Для цитирования: Grinspan Zachary M, Shellhaas Renée A, Coryell Jason, Sullivan Joseph E, Wirrell Elaine C, Mytinger John R, Gaillard William D, Kossoff Eric H, Valencia Ignacio, Knupp Kelly G, Wusthoff Courtney, Keator Cynthia, Ryan Nicole, Loddenkemper Tobias, Chu Catherine J, Novotny Edward J, Millichap John, Berg Anne T. Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy.. JAMA pediatrics. 2018. DOI: 10.1001/jamapediatrics.2017.5211.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.